Lv4
690 积分 2023-09-27 加入
SEL120-34A is a novel CDK8 inhibitor active in AML cells with high levels of serine phosphorylation of STAT1 and STAT5 transactivation domains
3个月前
已完结
Discovery and Development of Cyclin-Dependent Kinase 8 Inhibitors
6个月前
已完结
Cancer Nanotechnology: A New Revolution for Cancer Diagnosis and Therapy
6个月前
已完结
S -nitrosoglutathione reductase as a therapeutic target for diabetic vascular complications in rodent models
10个月前
已完结
皖公网安备34019202002308
